INS and type 2 diabetes mellitus: Therefore, the aims of this study were to investigate (1) the prevalence of hyperinsulinemia (2), the differences between the clinical characteristics of patients with immunity-induced and real hyperinsulinemia, and (3) the clinical implications of FINS levels in patients with type 2 diabetes who were treated with insulin or insulin analogs.